Bausch + Lomb Earnings
NYSE: BLCOHealth CareOphthalmic GoodsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Oct 28, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$0.21
Bausch + Lomb earnings summary
Bausch + Lomb is scheduled to report Sep/2026 earnings on Oct 28, 2026 before the market opens, with analysts expecting EPS of $0.21. In its most recent report on Jul 29, 2026 (Q2 2026), BLCO posted EPS of $-0.04. Revenue for the quarter was $1.39 billion.
Across the last 16 reports, BLCO shares moved an average of 3.6% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
BLCO earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 29, 2026 | — | $-0.04 | — | -0.8% |
| Apr 29, 2026 | — | $-0.20 | — | -0.8% |
| Feb 18, 2026 | — | $-0.16 | — | +2.0% |
| Oct 29, 2025 | — | $-0.08 | — | +4.1% |
| Jul 30, 2025 | — | $-0.18 | — | +1.0% |
| Apr 30, 2025 | — | $-0.60 | — | -2.0% |
| Feb 19, 2025 | — | $0.00 | — | +1.6% |
| Oct 30, 2024 | — | $0.01 | — | -2.5% |
| Aug 1, 2024 | — | $-0.43 | — | -3.6% |
| May 1, 2024 | — | $-0.48 | — | +13.3% |
| Feb 21, 2024 | — | $-0.15 | — | -6.4% |
| Nov 1, 2023 | — | $-0.24 | — | -6.4% |
| Aug 2, 2023 | — | $-0.09 | — | +0.9% |
| May 3, 2023 | — | $-0.26 | — | +6.3% |
| Feb 22, 2023 | — | $0.00 | — | -3.1% |
| Nov 2, 2022 | — | $-0.05 | — | +2.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.